This company has been marked as potentially delisted and may not be actively trading. Lianluo Smart (LLIT) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrendsBuy This Stock LLIT vs. CATX, INFU, NSPR, CTCX, TMDIF, HSAQ, GBS, RVP, PETV, and BTCYShould you be buying Lianluo Smart stock or one of its competitors? The main competitors of Lianluo Smart include Perspective Therapeutics (CATX), InfuSystem (INFU), InspireMD (NSPR), Carmell (CTCX), Titan Medical (TMDIF), Health Sciences Acquisitions Co. 2 (HSAQ), GBS (GBS), Retractable Technologies (RVP), PetVivo (PETV), and Biotricity (BTCY). These companies are all part of the "medical" sector. Lianluo Smart vs. Its Competitors Perspective Therapeutics InfuSystem InspireMD Carmell Titan Medical Health Sciences Acquisitions Co. 2 GBS Retractable Technologies PetVivo Biotricity Perspective Therapeutics (NYSE:CATX) and Lianluo Smart (NASDAQ:LLIT) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, media sentiment, profitability and risk. Which has preferable earnings and valuation, CATX or LLIT? Lianluo Smart has higher revenue and earnings than Perspective Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPerspective TherapeuticsN/AN/A-$46.51MN/AN/ALianluo Smart$380K219.76-$4.45MN/AN/A Do analysts recommend CATX or LLIT? Perspective Therapeutics presently has a consensus target price of $12.56, indicating a potential upside of 267.66%. Given Perspective Therapeutics' stronger consensus rating and higher probable upside, equities research analysts clearly believe Perspective Therapeutics is more favorable than Lianluo Smart.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Perspective Therapeutics 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 3 Strong Buy rating(s) 3.18Lianluo Smart 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility and risk, CATX or LLIT? Perspective Therapeutics has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500. Comparatively, Lianluo Smart has a beta of 0.16, indicating that its stock price is 84% less volatile than the S&P 500. Does the media prefer CATX or LLIT? In the previous week, Perspective Therapeutics had 3 more articles in the media than Lianluo Smart. MarketBeat recorded 3 mentions for Perspective Therapeutics and 0 mentions for Lianluo Smart. Lianluo Smart's average media sentiment score of 0.00 beat Perspective Therapeutics' score of -0.20 indicating that Lianluo Smart is being referred to more favorably in the news media. Company Overall Sentiment Perspective Therapeutics Neutral Lianluo Smart Neutral Is CATX or LLIT more profitable? Lianluo Smart has a net margin of 0.00% compared to Perspective Therapeutics' net margin of -4,096.66%. Lianluo Smart's return on equity of 0.00% beat Perspective Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Perspective Therapeutics-4,096.66% -27.40% -23.16% Lianluo Smart N/A N/A N/A Do institutionals & insiders believe in CATX or LLIT? 54.7% of Perspective Therapeutics shares are held by institutional investors. Comparatively, 28.8% of Lianluo Smart shares are held by institutional investors. 3.5% of Perspective Therapeutics shares are held by insiders. Comparatively, 22.9% of Lianluo Smart shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryPerspective Therapeutics and Lianluo Smart tied by winning 7 of the 14 factors compared between the two stocks. Get Lianluo Smart News Delivered to You Automatically Sign up to receive the latest news and ratings for LLIT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LLIT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LLIT vs. The Competition Export to ExcelMetricLianluo SmartSurgical & Medical Instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$83.51M$80.96M$5.80B$10.16BDividend YieldN/AN/A5.69%4.61%P/E RatioN/A11.4974.6226.00Price / Sales219.76113.19468.1791.50Price / CashN/A18.4137.0859.91Price / Book-64.0210.9812.156.30Net Income-$4.45M-$26.48M$3.28B$270.75M Lianluo Smart Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LLITLianluo SmartN/A$37.77+5.2%N/A+4,817.8%$83.51M$380K0.006High Trading VolumeCATXPerspective Therapeutics1.7335 of 5 stars$3.38+1.8%$12.56+271.5%-78.4%$251.01MN/A0.0070INFUInfuSystem3.3603 of 5 stars$10.55-0.3%$12.50+18.5%+55.8%$215.49M$139.89M175.86410Positive NewsNSPRInspireMD3.7041 of 5 stars$2.43flat$4.50+85.2%-9.7%$101.38M$7.07M-3.2450Short Interest ↓CTCXCarmellN/A$2.58+1.6%N/A+464.9%$53.94M$32.84K0.0014TMDIFTitan MedicalN/A$0.34+4.8%N/A+782.9%$38.45M$17.63M-0.2750HSAQHealth Sciences Acquisitions Co. 2N/A$2.74+0.4%N/A-53.0%$30.72MN/A0.004GBSGBSN/A$1.62-1.8%N/A-16.7%$24.12MN/A-2.897RVPRetractable Technologies1.2647 of 5 stars$0.79-0.8%N/A-10.3%$23.65M$38.16M-1.46240Short Interest ↑PETVPetVivoN/A$0.80+0.7%N/A+44.8%$22.32M$1.05M-1.7820News CoverageBTCYBiotricityN/A$0.67+15.7%N/A+98.3%$16.68M$12.06M-0.6240Gap DownHigh Trading Volume Related Companies and Tools Related Companies Perspective Therapeutics Competitors InfuSystem Competitors InspireMD Competitors Carmell Competitors Titan Medical Competitors Health Sciences Acquisitions Co. 2 Competitors GBS Competitors Retractable Technologies Competitors PetVivo Competitors Biotricity Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LLIT) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored2013 Bitcoin miner reveals his trading system (free)There are 18,347 cryptocurrencies in the market right now. 99% of them will fail. And trying to pick winner...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lianluo Smart Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Lianluo Smart With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LLIT Stock Alerts